Experimental Application of Betamethasone 17, 21-Dipropionate (Rinderon DP Ointment and Cream) on Various Skin Diseases

• Published in: Skin research Vol. 27; no. 6; pp. 1228 - 1235
• Main Authors: KAMIMURA, Kimio, TONE, Takeshi, ETO, Hikaru, KATO, Ichiro, HASHIMOTO, Akihiko, MUKAI, Hideki, ASAI, Toshiya, NISHIYAMA, Shigeo
• Format: Journal Article
• Language: English; Japanese
• Published: Meeting of Osaka Dermatological Association 1985; 日本皮膚科学会大阪地方会
• Subjects: ジプロピオン酸ベタメタゾン外用剤; 使用経験; 各種皮膚疾患
• ISSN: 0018-1390; 1884-541X
• DOI: 10.11340/skinresearch1959.27.1228

Effectiveness, side effect and usefulness of Rinderon DP ointment and cream each containing 0.64mg/g of betamethasone 17, 21-dipropionate were investigated. Totally, 40 patients with discoid lupus erythematosus, lichen planus, idiopathic pigmentary purpura, granuloma annulare, malignant lymphoma and similar diseases, skin-limited amyloidosis and bullous diseases such as pemphigus groups and bullous pemphigoid were subjected to the test. Of these 40 cases, 31 (77.5%) showed effectiveness to be graded as “fairly improved” or better, however, side effects were observed only in 2 cases (5%). In terms of effectiveness and side effects, the drug was judged as a grade of “useful” or better in 30 cases (75%), an extremely high rate. Though patients with such inveterate skin diseases were tested in this study, relatively high rates of effectiveness and usefulness of the drug were obtained.